Objective: To report disease-causing mutations in the cyclic nucleotide-gated channel ␣ 3 gene (CNGA3) identified by exome sequencing and bioinformatics filtering in a single patient.
O
VER THE LAST QUARTER century, advances in ophthalmic molecular g e n e t i c s h a v e b e e n driven to a large extent by new DNA technology. Technological advances in DNA sequencing and widely accessible databases of annotated human genomic sequences are creating a new paradigm for the study of rare ocular genetic diseases. The transforming technology is massively parallel sequencing of the entire genome of individual persons, which is also known as next-or secondgeneration sequencing. 1 While the high cost of this new technology is preventing full realization of its effects at this time, a slightly restrictive application is making substantial headway in the analysis of mendelian disorders. 2 The new method targets and captures the 180 000 exons (collectively called the exome) dispersed within the human genome for sequencing with the same depth of coverage as whole-genome sequencing and at a much lower cost. 3, 4 The rationale for this approach is that, while the protein-coding regions compose only 1% of the genome, it is in this portion that 85% of diseasecausing mutations occur. 5 Thus, massively parallel sequencing of this 1% of human DNA (approximately 30 million bases in length) is a cost-effective and efficient way to identify pathogenic mutations of mendelian diseases. Several recent articles have described the successful application of this method, using for analysis DNA from only a few subjects. 3, [5] [6] [7] [8] [9] [10] [11] [12] To apply whole-exome sequencing and bioinformatics filtering to the study of rare genetic eye disorders, we sequenced the exome of a single patient. As expected,approximately15 000 genetic variants were identified in this individual's exome se-quence. By applying a few general screening criteria (filters) in the subsequent bioinformatics analysis to separate the background polymorphisms from diseasecausing mutations, we aimed to make an accurate molecular diagnosis. The only clinical information used for bioinformatics filtering was that the patient has a retinal disorder. In our study, this general filtering scheme quickly identified 2 heterozygous mutations in the CNGA3 gene, which is known to associate with autosomal recessive achromatopsia. 13 
METHODS

FRAGMENT LIBRARY CONSTRUCTION
Genomic DNA was isolated from the blood sample using the Gentra Puregene blood kit (Qiagen, Valencia, California). A fragment library of genomic DNA was prepared by using the SOLiD fragment library construction kit (Life Technologies, Carlsbad, California). In brief, 3 µg of genomic DNA was fragmented into lengths ranging from 100 to 150 base pairs (bp) using a Covaris S2 System (Covaris, Woburn, Massachusetts). After end repair, the DNA was ligated with P1 and P2 adaptors from the SureSelect AB adaptor kit (Agilent, Santa Clara, California). Size selection of 150-to 200-bp DNA fragments was performed on a SOLiD library size selection gel (Life Technologies), followed by nick translation and 12-cycle polymerase chain reaction amplification. The quantity and quality of the amplified fragment library was assessed by an Agilent 2100 bioanalyzer before enrichment.
TARGETED CAPTURE AND EXOME SEQUENCING
From the prepared fragment library, 500 ng was enriched for exons by using the SureSelect human all-exon kit (version 1; Agilent). The kit was designed to enrich for all the coding sequences covering a total of 38 megabases in length. In brief, the prepared DNA was in-solution hybridized with SureSelect biotinylated RNA baits for 24 hours at 65°C, and the captured DNA-RNA hybrid library was purified by streptavidin-coated magnetic beads. After digestion of the RNA baits, the captured DNA library was further amplified and used for emulsion polymerase chain reaction according to the manufacturer's instructions (Life Technologies), based on a library concentration of 0.5pM. The amplified library was then sequenced as singleend 50-bp reads on a SOLiD 3 plus system (Life Technologies). The sample was run on 1 quad of a SOLiD sequencing slide (Life Technologies). A second amplified library was obtained from the same captured library and sequenced independently.
BIOINFORMATICS ANALYSIS
The 50-bp SOLiD reads were mapped to human genome hg18 in color space using Bowtie version 0.12.3 (http://bowtie-bio .sourceforge.net). Genetic variants were called using SAMtools (http://samtools.sourceforge.net/); nonsynonymous variants were labeled using ANNOVAR (http://www.openbioinformatics .org/annovar/). Further filtering was performed (1) with a prioritization of genes known to associate with retinal disorders (a list of 177 genes from RetNet, http://www.sph.uth.tmc .edu/retnet/), (2) by the PolyPhen-2 Web resource (http://genetics.bwh.harvard.edu/pph2/) 14 based on high likelihood of damage (pph2 prob Ͼ0.9) to protein function caused by a variant, (3) by applying a recessive model, ie, either 2 heterozygous mutations occurring in the same gene or a homozygous mutation, and (4) by removing common polymorphisms observed in a pool of normal genomes (http://browser.1000genomes.org/index.html). 15 Reads generated from the second amplified library were assembled in the same manner as described, and the coverage at the 2 mutation sites was determined.
MUTATION AND SEGREGATION ANALYSES
Exon 7 and flanking intronic sequences of the CNGA3 gene were amplified by polymerase chain reaction with genomic DNA as templates (primer sequences: forward 5Ј-TCAGAGTGCATTTCCT-GTAGT-3Ј and reverse 5Ј-GCTTTCAAAGGGTGAGTAGA-3Ј). 16 Amplicons were sequenced using the ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction Kit (PerkinElmer Applied Biosystems, Foster City, California) and separated on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). Sequencing primers were the following: for c.829CϾT p.R277C 5Ј-GCATACTGTGTAGCCGTGAGG-3Ј and for c.1580TϾG p.L527R 5Ј-GTGGGCAATGTGGGCTCC-3Ј. Editing, sequence alignment, and mutation detection were performed applying the Lasergene Software package (DNASTAR; Lasergene, London, England).
Segregation analysis by DNA sequencing for the presence and independent inheritance of 2 mutant alleles was performed in all family members. Mutations were excluded in 100 healthy (European descent) control samples (200 chromosomes) by direct DNA sequencing.
RESULTS
BIOINFORMATICS ANALYSIS
From the captured library, 91 346 458 fifty-bp SOLiD reads were generated. Of these, 57 330 833 reads (62.7%) had at least 1 reported alignment to human genome hg18; 56.19% were on target, and 84.30% mapped to only 1 site. The mapped readings provided 49.77-fold coverage (range, 0-5705ϫ) for the targeted exon sequences; 80.81% of bases were covered at more than 7-fold depth (eFigure; http://www.archophthalmol.com). Using SAMtools and a cutoff equal to or greater than 20 of the Phredlike quality score, 62 518 variants were called; 15 292 were exonic variants. Of these, ANNOVAR identified 7680 nonsynonymous variants; 3533 were not in dbSNP130. The types of variants identified, including indels and splicesite variants, are summarized in eTable 1. Further filtering with a prioritization of genes known to associate with retinal disorders reduced the list to 102 variants associated with 51 genes. Selecting variants on the basis of predicted damage to protein function by PolyPhen-2 resulted in a list of 13 genes and 15 variants. By applying a recessive model, this list was shortened to 5 genes and 7 variants. Screening these 7 variants against the 1000 Genomes Project Consortium database 15 identified 3 common polymorphisms previously observed in normal genomes; this fact led to the elimination of a fourth variant based on a recessive model (eTable 2). The list of candidate genes was thus reduced to 2: CNGA3 with 2 heterozygous candidate mutations and TLR3 with 1 homozygous candidate mutation.
Literature review indicated that TLR3 (toll-like receptor 3, also known as CD283) encodes a member of the toll-like receptor family, which plays a fundamental role in pathogen recognition and activation of innate immunity. It was identified by association study as a candidate gene whose L412F polymorphism might be protective in patients with geographic atrophy related to agerelated macular degeneration; on this basis, it was included in RetNet. [17] [18] [19] Therefore, in this context, TLR3 is not a retinal disease gene. In contrast, CNGA3 is known to associate with achromatopsia, and one of the candidate mutations, c.829CϾT p.R277C, has previously been reported. 16 Therefore, knowledge about the 2 candidate genes overwhelmingly supported the hypothesis that the retinal disorder in question is achromatopsia and the proband carries 2 heterozygous mutations: c.829CϾT p.R277C and c.1580TϾG p.L527R, a novel CNGA3 mutation (Table, Figure 1, and Figure 2) . Sequencing coverage at c.829CϾT and c.1580TϾG are shown in the Table. All of the reads containing the 2 changes map to only 1 site.
CASE HISTORY AND CLINICAL FINDINGS
The proband (II:1; Figure 3 ) presented shortly after birth with nystagmus. It was noted that she was fascinated by bright lights but performed poorly in a bright environment and appeared to see better in the dark. There was no family history of ophthalmic disease, and the parents were not related. Examination at 9 months of age revealed absence of fixation, and she could not recognize faces in the light. A small-amplitude, rapid, pendular nystagmus was present and there was a paradoxical pupillary response. Findings of anterior segment, ocular media, and fundus examination were normal. The cycloplegic refraction was ϩ8.00 dioptrically sphere OU. A clinical diagnosis of achro- 
Wild-type Figure 3 ) also has achromatopsia.
MUTATION ANALYSIS AND SEGREGATION ANALYSIS
The mutations (Table and Figure 1 ) affect evolutionarily highly conserved amino acid residues in the CNGA3 protein ( Figure 2 ). In addition, the mutations were excluded in 100 healthy European control samples (200 chromosomes) by direct DNA sequencing (data not shown). Segregation analysis (Figure 3 ) proved the presence of 2 mutant alleles that were inherited independently and compound-heterozygously. Both the proband (II:1, Figure 3 ) and her affected brother (II:2, Figure 3 ) carried the 2 mutations p.R277C and p.L527R, while the unaffected brother (II:3, Figure 3 ) was a heterozygous carrier of the R277C allele, which was inherited with the paternal allele. The mother was heterozygous for the L527R mutation.
COMMENT Achromatopsia (rod monochromacy or total color blindness) is a congenital or early-onset retinal disorder with cone photoreceptor function loss. It is estimated to affect 1 in 30 000 individuals worldwide. 21 Clinically it is characterized by reduced visual acuity, pendular nystagmus, photophobia, small central scotomas, eccentric fixation, and reduced or complete loss of color discrimination. In ERG recordings, photopic (cone) responses are absent or markedly diminished, whereas scotopic (rod) responses are essentially normal and remain stable. Genetically, achromatopsia is a heterogeneous condition inherited as an autosomal recessive trait. To date, mutations in 4 genes are known to associate with this disorder.
The primary biological mechanism underlying achromatopsia is a defective cone phototransduction cascade (photopigment → G-protein transducin → phosphodiesterase/cGMP → CNG channel; for review, see the article by Lamb and Pugh 22 ). The 4 genes known to associate with achromatopsia are essential components of this cascade, CNGA3 13 and CNGB3, 23, 24 encoding the channelforming ␣ and the modulatory ␤ subunit of the conespecific cyclic nucleotide (cGMP)-gated cation channel (CNG), respectively; GNAT2 is the gene for the conespecific ␣ subunit of the G-protein transducin, [25] [26] [27] PDE6C encodes the ␣Ј subunit of the cone-specific phosphodiesterase. 28, 29 In a homologous CNGA3 knockout mouse model, the number of cone photoreceptors is decreased and the remaining cones showed abnormal morphology and degenerated; physiologically, measurable cone function was absent. 30 Taken together, results obtained from both animal model and human genotypephenotype correlations strongly support the notion that normal CNGA3 function is critical for cone phototransduction; mutations in the CNGA3 gene that damage CNGA3 protein function lead to achromatopsia.
The mutations identified in this study are most likely causative because of the expected damage to CNGA3 protein function and hence disruption of the cone phototransduction cascade. Arginine 277 is located in the highly conserved S4 transmembrane helix ( Figure 2) ; the R277C mutation has been shown by in vitro expression studies to result in disrupted channel biogenesis and stability. 31 The R277C mutation is observed recurrently in patients with achromatopsia and their families; it has been suggested that it might be owing to a founder mutation in patients of European descent. 16 Similarly, the novel mutation L527R affects a highly conserved leucine residue in the cGMP binding domain of the protein (Figure 2) , and an apparent clustering of achromatopsia-causing mutations in amino acid positions 510 to 529 has been observed. 16 Furthermore, another causative mutation that affects L527 and segregates within an unrelated achromatopsia family has been observed recently (S.K.).
In summary, (1) clinical examination of the family, (2) normal scotopic ERG but severely compromised photopic ERG of the proband, (3) mutations deemed to disrupt CNGA3 protein function, and (4) 100% concordance of genotype and phenotype in this family provide strong evidence that the 2 compound heterozygous mutations, p.R277C and p.L527R, are the achromatopsiacausing mutations in this family.
An effective filter used in the present study was limiting the search to genes known to associate with retinal disorders; it streamlined the process to the correct end point. For mutations that occur in genes not already known to be associated with retinal disorders, the same filter would have misguided the process away from the causative mutations. An alternative strategy would be selection of variants that are private to the family, ie, variants observed in the proband's immediate family but perhaps not in the general population. From this subset, selection of variants that are present only in affected individuals would narrow the search significantly. This strategy was used successfully in identifying mutations underlying Joubert syndrome 2 (mother and affected daughter). 8 In addition to comparing private variants of closely related individuals, comparisons can be made of unrelated individuals who have the same clinical phenotype. The rationale is that the same mutation, or different mutations affecting the same gene, may be causative for individuals sharing the same phenotype. This filter was used in the identification of mutations underlying Kabuki syndrome (10 unrelated cases), 9 Schinzel-Giedion syndrome (4 unrelated cases), 10 and Fowler syndrome (2 unrelated cases).
11 The 2 alternative filters described here can be incorporated easily into the high-throughput bioinformatics filtering scheme. Furthermore, the principles outlined here apply equally well to retinal disorders, corneal diseases, or other ocular disease subgroups.
Selecting variants according to the high likelihood of damage to protein function has been used successfully in several studies. 4 However, there is a graded scale of potential damage; where to draw the line in the highthroughput screening is not always clear-cut. The same difficulty affects filtering by mutation frequency. 2, 6 No doubt, better quantitative models are being developed to address these issues. In the meantime, successful identification of causative mutations for mendelian disorders depends largely on the circumstance of each case; furthermore, different filtering procedures and parameters can lead to the same correct mutation identification.
From the outset, it is clear that exome sequencing would fail to identify some disease-causing mutations (eAppendix). Nevertheless, the odds are in favor of success, especially when viewed in the context of a large number of attempts. When this more restrictive but cost-effective approach fails, the default would be whole-genome sequencing. Several rare diseases have been analyzed successfully by this exhaustive and more expensive method, eg, Miller syndrome, 32 metachondromatosis, 33 severe hypercholesterolemia, 34 and Charcot-Marie-Tooth disease. 35 Therefore, the new DNA sequencing technology has made it feasible, for the first time, to identify the genetic cause of the rarest forms of disorders, with only single or very few affected individuals. 
